trial · primary record
Vutrisiran
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 655 |
| Primary completion | 2027-01-13 |
| Primary endpoint | Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular (CV) Events (CV Hospitalizations and Urgent Heart Failure [HF] Visits) in the Overall Population |
| Registry ID | NCT04153149 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:45.489Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04153149
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.